The aim: The purpose of the research is to study the understanding of student pharmaceutical youth the eating behavior in the context of the EBW and obesity.
Materials and methods: The material of the study was anonymous questionnaire survey the students of the pharmaceutical faculties from Ukraine.
Results: The results of the questionnaire were analyzed using methods of statistics, comparison and generalization. Almost 9 out of 10 respondents from both universities
consider the reason of obesity a sedentary lifestyle and poor nutrition, and the most effective way to treat it is physical activity, though only 36.3% and 28.4% of students of
the corresponding samples have it constantly.
Conclusions: The questionnaire showed a lack of eating behavior, of their knowledge of the basic issues of the EBW and obesity, as well as differences in personal perception
and the desire for the practical implementation of queries regarding the weight of their body that may further affect the professional ability of young specialists in influencing
the processes of formation and improving the quality of their lives and patients’ lives.

Ischemic stroke belongs to the leading causes of death and disability in the world and Ukraine. The surviving rates depend on the quality of the provided medical care. The research aimed to analyze the quality of medical care related to pharmacotherapy of ischemic stroke. The clinical indicators for quality are the quantitative or qualitative indicants that have evidence or consensus of direct influence on it. Six of them relate to acute ischemic stroke
pharmacotherapy (namely, thrombolytic, antiplatelet, anticoagulant, and lipid-lowering agents use at different stages of hospital stay) and were investigated in this retrospective analysis of 151 patients’ medical records of one of the specialized hospital departments in Lviv city. The clinical indicators for quality of medical care showed that pharmacological treatment using antithrombotics (antiplatelets and anticoagulants) at the admission to the hospital
corresponded to standards and quality was defined as high with rates of 65.6% and 85.4%. At discharge, the indicator analysis of pharmacotherapy revealed existing problems for antithrombotic (2 indicators) and lipid-lowering (1 indicator) pharmacotherapy with rates of 33.3% and 47.7%.
The outcomes concluded the existence of problems related to pharmacotherapy. The complex of three algorithms was introduced to improve the quality of medical care. 

Abstract

Diabetic retinopathy (DR) is the most significant and common cause of visual impairment in diabetes patients. The aim of the study was to enhance the understanding of the pathogenesis of DR associated with metabolic syndrome (MS) and elucidate the role of cellular and humoral immunity factors. The study included 130 patients. Group 1 comprised 70 patients diagnosed with DR and insulin-dependent type 2 diabetes against the background of MS. Group 2 included 60 patients diagnosed with DR and non-insulin-dependent type 2 diabetes associated with MS. The immunological analysis focused on evaluating subpopulations of blood lymphocytes using flow cytometry; systemic inflammation markers, such as CRP, specific IgA, IgM, and IgG, cytokines measured by ELISA. Significant changes in immune status were observed in patients with DR associated with MS, depending on diabetes compensation. In Group 1 patients with DR, more pronounced alterations in the T-cell immunity pathway were observed, including T-cell immunodeficiency accompanied by the activation of killer and B-cell immunity, compared to non-insulin-dependent patients. Both groups exhibited type IV hypersensitivity reactions. Elevated CRP level was detected only in insulin-dependent patients with DR. An analysis of the immune parameters indicated predominant activation of the specific humoral immunity pathway, suggesting chronicity of the condition. Non-insulin-dependent patients showed significant activation of mucosal humoral defenses and early humoral protective mechanisms. The data revealed more pronounced changes in specific humoral immunity markers, such as immunoglobulins, compared to systemic inflammation markers like CRP.

Introduction
War is a relentless force that leaves no aspect of life untouched, weaving itself into the fabric of
daily existence and reshaping even the most intimate connections. This story, written from the
perspective of a mother, a wife, and a professional, seeks to capture the enduring effects of war
on relationships, identity, and resilience.
2021: Prelude
“Froggy, I’m thinking of getting an AR-15. I want to learn how to shoot.”
“I thought hunters knew how to shoot.”
“That’s different. I need to learn how to shoot in warfare.”
“Come on. They won’t dare.”
February 24th, 2022: The first day
The day began with a summons. My husband, part of the territorial defense forces, became a
company commander. I was left with our three children, glued to the news, unable to leave the
house.
The weight of resentment
During those first weeks, my emotions spiraled between resentment, anger and despair. The
injustice felt suffocating. My husband, a father of three, was not supposed to be sent to war. Why
him?The days were a blur of rage and survival. The uncertainty of his safety permeated every
waking thought.
A constant state of waiting
Every day began with checking his messages: “Good morning, everyone, everything’s fine.”
A short, reassuring phrase that became a lifeline. But the thoughts came anyway. What if he’s
injured? What if he loses a limb? His eyesight? His mind?
The first death
In autumn, the war claimed its first victim from his company. Standing at the military burial
field during the funeral, I couldn’t help but think: “I don’t want my husband to lie here. I want
my grave to be next to his.”
The burden of survival
In the winter his battalion was moved to Kreminna. The place used to be a nature reserve with
lush pines now all turned into charred stumps. My husband, always protective, shared little.
Desperation drove me to check his messages one day. What I found was a video of one of his
soldiers captured by the Russians, naming my husband among his commanding officers.
Eventually, he was demobilized after the remnants of his company were withdrawn from the
frontline. He returned home, miraculously with only two concussions.
Life after the frontline
Though physically unscathed, nothing is truly the same. He resumed the rhythms of family life,
attending school functions and teaching our son to ride a bike. I watched for signs of trauma, but
he remained the man I married–resilient and kind.
Yet, the shadow of war lingers. The awareness of how close we came to losing each other has
deepened our connection. Petty disagreements seem absurd now. But the memories of loss–of
others’ losses–are never far away.
Every time there’s a POW exchange I scan the list for that young soldier’s name, and it’s never
there.It’s been two years.
A fragile hope
On the morning of my son’s seventh birthday, drones and missiles attacked our city. As we
rushed to the basement, my husband, unbelievably, counted the explosions.
“Is it like this on the frontline?”
“No, Froggy. It’s much worse.”
Conclusion
This story has no ending. It is one of countless others–stories of bravery, grief, resilience, and
loss. Stories that must be told again and again, in the hope that by bearing witness, we can create
change.

УДК 615.12:339.162(477.84)
Мета роботи. З’ясування наявних організаційно-правових форм суб’єктів фармацевтичного підприємництва та аналіз особливостей їхньої структури й локалізації в територіально-адміністративних одиницях Тернопільської області.Матеріали і методи. Матеріали дослідження: Реєстр місць провадження діяльності з оптової та роздрібної торгівлі лікарськими засобами (ЛЗ), статистичні дані щодо населення Тернопільської області. Використано методи інформаційного пошуку, системного і статистичного аналізу, порівняння та узагальнення.
Результати й обговорення. Встановлено, що на території Тернопільської області станом на 28.02.2020 р. з 290 суб’єктів підприємницької діяльності (СПД), які мають ліцензію на оптову і роздрібну торгівлю ЛЗ, 257 зареєстровані в області, решта – в інших регіонах України. Фармацевтичне забезпечення здійснюють 4 аптечні склади, 523 аптеки та 99 аптечних пунктів. Майже три четвертих місць провадження діяльності з роздрібної реалізації ЛЗ належать СПД, що зареєстровані у Тернопільській області. В містах зосереджено понад двох третіх, зокрема в м. Тернопіль – третина, від усіх місць провадження діяльності з роздрібної реалізації ЛЗ. Власниками майже половини аптечних закладів (АЗ) є фізичні особи-підприємці (ФОП), понад двох п’ятих – товариства з обмеженою відповідальністю (ТзОВ), решта – комунальні та приватні підприємства і підприємства колективної власності. Ліцензію на виробництво ЛЗ мають лише 9 аптек. За забезпеченістю АЗ й щільністю населення адміністративно-територіальні одиниці Тернопільської області розподілилися на 8 з 10 кластерів за наявності кластера-лідера – м. Тернопіль. Розподіл районів має значну асиметрію – низький рівень забезпечення АЗ характерний для трьох, а мала щільність населення – для семи районів із 17-ти. Висновок. За результатами дослідження встановлено, що: фармацевтичне забезпечення населення Тернопільської області здійснюють СПД різних організаційно-правових форм господарювання, більшість серед яких становлять ФОП і ТзОВ; порівняно з минулим роком кількість АЗ зменшилася внаслідок суттєвого скорочення місць провадження діяльності ФОП; частка мережевих аптек складає третину від усіх СПД фармацевтичного ринкуТернопільщини, а за кількістю місць провадження діяльності їх удвічі більше; у сільській місцевості розміщені менше третини АЗ, що перевищує аналогічний показник по Україні; лише 1,4 % АЗ мають ліцензію на виробництво ЛЗ, що на 0,2 % менше, ніж в середньому по Україні; забезпечення АЗ у сільській місцевості у 2,8 раза нижче, ніж у міській; спостерігається суттєва диференціація адміністративно-територіальних одиниць за забезпеченістю АЗ й щільністю населення.